Impli awarded £1.4M NIHR grant to advance world-first continuous hormone monitoring
The award will fund a 30-month consortium programme bringing together PHTA-based Impli, Imperial College Healthcare NHS Trust, King’s College London, and Fertility Europe to take the BEAM biosensor from prototype to first-in-human clinical validation. Impli, the deep-tech company developing the first continuous molecular monitoring platform for hormonal health at PHTA, has been awarded a £1.4 […]
PHTA and MedTech Makers Lab launch collaboration to bring global innovators to Birmingham
The University of Birmingham’s Precision Health Technologies Accelerator (PHTA) has established a strategic partnership with MedTech Makers Lab Ltd (MML) to bring high-potential, international medtech and life sciences companies into the West Midlands. The collaboration will see MML and PHTA work together to attract high-growth international companies into Birmingham’s health and life sciences district, supporting […]
£1.4 million secured for new PHTA cleanroom manufacturing facility
University Hospitals Birmingham (UHB) has secured £1.4 million from the National Institute for Health and Care Research (NIHR) to support the development of a new cleanroom manufacturing facility within PHTA. The 440 sq m facility will provide specialist capability for the preparation and early-stage manufacture of innovative medicines and advanced therapies for use in NHS […]
Pioneering health innovation in Birmingham: five minutes with our CEO
Ahead of the Greater Birmingham Chamber of Commerce Awards, where we’ve been shortlisted in the Pioneer category, we spoke to CEO Professor Gino Martini about the vision behind the facility, the partnerships that helped bring it to life, and its role in supporting the next generation of health and life sciences businesses in Birmingham. From […]
Choosing lab space: a guide for life sciences start-ups
For life sciences and medtech start-ups, finding the right lab space can be a defining decision. The right environment can help accelerate your research, attract talent and investors, and grow your business with confidence. The wrong one can create delays, raise costs and stall growth. For early-stage companies, securing the right lab space early can […]
US-UK nanotech partners drive global push for equitable diagnostics
A pioneering partnership between the University of Birmingham’s Clinical Immunology Services (CIS) and the University of Illinois Urbana-Champaign is driving forward a new generation of ultra‑sensitive, affordable diagnostic technologies aimed at reducing global health inequalities. The diagnostic divide between the Global North and Global South continues to limit access to essential tests, with nearly half […]
Impli to accelerate real-time hormone monitoring technology at Birmingham’s PHTA
Impli, a pioneering health technology company developing implantable biosensors for real-time hormone monitoring, has become the first commercial lab resident at Birmingham’s PHTA, targeting team growth, human trials and manufacturing readiness. Focusing initially on improving women’s health, Impli’s platform is designed to help clinicians and patients understand hormonal fluctuations to make better-informed treatment decisions […]
Multi-million pound investment brings advanced biological medicines manufacturing to PHTA
Pharmaceutical researchers and enterprises will soon be able to make advanced therapeutics such as mRNA vaccines for cancer in three new, dedicated commercial cleanrooms at the University of Birmingham’s Precision Health Technologies Accelerator (PHTA). Announced today by the UK Government’s Department for Science, Innovation and Technology, the funding has been unlocked by the Life Sciences Innovative […]
How mRNA vaccines could beat pancreatic cancer
Birmingham is leading the way in personalised mRNA vaccine trials, with near-patient biomanufacturing facilities coming soon to PHTA Fighting the deadliest of cancers The outlook for a patient with pancreatic cancer is bleak. The disease is often caught late and tends to be highly aggressive, reducing treatment options. Standard therapies are gruelling and, for many […]
New saliva test for tetanus immunity set for evaluation in Rwanda
Researchers from the University of Birmingham’s Clinical Immunology Services have developed a simple saliva test to identify tetanus immunity status in the Global South. In a programme of work backed by £1.1 million of Medical Research Council funding, researchers have worked with industry partner, Medtechtomarket, to create a low-cost, lateral flow point-of-care test that enables immunity […]